A Systematic Review of Atypical Antipsychotics in Chronic Pain Management: Olanzapine Demonstrates Potential in Central Sensitization, Fibromyalgia, and Headache/Migraine

@article{Jimenez2018ASR,
  title={A Systematic Review of Atypical Antipsychotics in Chronic Pain Management: Olanzapine Demonstrates Potential in Central Sensitization, Fibromyalgia, and Headache/Migraine},
  author={Xavier F. Jimenez and Tharani Sundararajan and Edward C. Covington},
  journal={The Clinical Journal of Pain},
  year={2018},
  volume={34},
  pages={585–591}
}
Introduction: Many psychopharmacologic agents are used as primary or adjuncts in pain management. [...] Key Method Articles chosen for review included retrospective analyses, randomized control trials, and case series/reports. A Preferred Reporting Items for Systematic Reviews and Meta-Analyses diagram illustrates the study selection process. Results: Olanzapine, quetiapine, risperidone, aripiprazole, and ziprasidone are the only AAs with published studies in pain management. Among these, olanzapine and…Expand
The Utilization of Atypical Antipsychotics in the Pain Medicine Physician's Armamentarium.
TLDR
The collective findings of multiple studies evaluating olanzapine in pain syndromes suggest a high, yet preliminary level of evidence of efficacy, warranting prospective studies in various pain syndrome contexts. Expand
Beyond Amitriptyline: A Pediatric and Adolescent Oriented Narrative Review of the Analgesic Properties of Psychotropic Medications for the Treatment of Complex Pain and Headache Disorders
TLDR
A narrative review hopes to supplement the available treatment options for children with recurrent or chronic pain and headache by reviewing the pediatric and adult literature for analgesic properties of medications that also have psychiatric indication. Expand
Pain Sensitivity in Schizophrenia Spectrum Disorders: A Narrative Review of Recent Work
TLDR
A non-systematic, narrative review focusing on recent clinical and experimental findings of pain sensitivity in patients with psychosis suggests that decreased pain sensitivity may represent a specific psychosis endophenotype. Expand
The Benefits of Olanzapine in Palliating Symptoms
TLDR
Olanzapine has become a major drug in the management of chemotherapy-induced nausea and vomiting as a prophylactic agent and is likely to become the antiemetic of choice in palliative care at least in the USA. Expand
Psychotropics, Antidepressants, and Visceral Analgesics in Functional Gastrointestinal Disorders
TLDR
Basic knowledge about the pharmacologic properties and clinical use of neuromodulators in disorders of brain-gut interaction improves the treatment outcome and avoids use of traditional analgesics. Expand
Current management strategies for the pain of elderly patients with burning mouth syndrome: a critical review
TLDR
Currently hopeful management strategies, including central neuromodulators (Tricyclic Antidepressants - TCAs, Serotonin, and Norepinephrine Reuptake Inhibitors - SNRIs, Selective Serotonin Reuptakes - SSRIs), and solutions for applying non-pharmacology approaches are discussed. Expand
Loxapine for Treatment of Patients With Refractory, Chemotherapy-Induced Neuropathic Pain: A Prematurely Terminated Pilot Study Showing Efficacy But Limited Tolerability
TLDR
The hypothesis that Slack activation might be a novel strategy for neuropathic pain therapy is supported, however, loxapine is no valid treatment option for painful polyneuropathy due to profound dopamine and histamine receptor-related side effects. Expand
Behavioral Medicine Assessment and Medication Choice in the Management of Chronic Pain
The goal of this chapter is to discuss the critical role of a behavioral medicine specialist in the management of chronic pain as well as assist in choosing the most appropriate psychotropicExpand
Clinical Correlates and Outcome of Major Depressive Disorder and Comorbid Migraine: A Report of the European Group for the Study of Resistant Depression
TLDR
Treatment guidelines for comorbid depression and migraine are warranted to ensure optimal efficacy and avoid possible pitfalls in psychopharmacotherapy, including serotonin syndrome. Expand
Association between psychotropic drug use and prescription opioid use among older adults.
TLDR
High dosage opioid use was significantly associated with anxiolytic/sedative/hypnotic use, antidepressant use and other factors including being younger, male, white, and married but living separately, and having multiple opioid prescribers. Expand
...
1
2
...

References

SHOWING 1-10 OF 73 REFERENCES
Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis.
TLDR
Benefits and harms vary among atypical antipsychotic medications for off-label use, and quetiapine was associated with benefits in the treatment of generalized anxiety disorder; however, adverse events were common. Expand
Antipsychotics for acute and chronic pain in adults.
TLDR
Antipsychotics might be used as an add-on therapy in the treatment of painful conditions and extrapyramidal and sedating side effects have to be considered before using antipsychotics for treating painful conditions. Expand
Do the second-generation "atypical neuroleptics" have analgesic properties? A structured evidence-based review.
TLDR
It was concluded that the reviewed data were generally consistent, suggesting that some of the atypical neuroleptics may have an analgesic effect. Expand
Atypical antipsychotics in the treatment of fibromyalgia: a case series with olanzapine
TLDR
The preliminary findings suggest a possible role for olanzapine in treating fibromyalgia, but the beneficial outcome of olanZapine was largely obscured by its poor tolerability, which could be explained by the greater propensity of patients with Fibromyalgia to adverse drug reactions, and the greater risk of antipsychotic-induced weight gain among women. Expand
Add-on Treatment of Quetiapine for Fibromyalgia: A Pilot, Randomized, Double-Blind, Placebo-Controlled 12-Week Trial
TLDR
This trial sought to examine the efficacy and tolerability of quetiapine as a treatment for FM and its associated psychiatric symptoms, and observed significant benefits of drug treatment on sleep, uncertain effects on FM and mood symptoms, but no effects on pain. Expand
Decreased Pain and Improved Quality of Life in Fibromyalgia Patients Treated with Olanzapine, an Atypical Neuroleptic
TLDR
The data provide strong support that olanzapine can, in certain patients, improve symptoms associated with fibromyalgia in patients who have had limited success with other treatment modalities. Expand
Olanzapine in the management of cancer pain.
TLDR
It is concluded that olanzapine may be useful in the treatment of patients with uncontrolled cancer pain associated with cognitive impairment or anxiety, and may have resulted from improvement in cognitive function and the known anxiolytic effect of olanZapine. Expand
Systematic Review of Antidepressants in the Treatment of Chronic Low Back Pain
TLDR
Based on a small number of studies, tricyclic and tetracyclic antidepressants appear to produce moderate symptom reductions for patients with chronic low back pain, and this benefit appears to be independent of depression status. Expand
Olanzapine as an add-on treatment in migraine status: A randomized double-blind, placebo-controlled, pilot study
TLDR
Olanzapine was well tolerated and sedation was welcomed by most subjects and the positive effect in subjects aged . Expand
An open pilot study assessing the benefits of quetiapine for the prevention of migraine refractory to the combination of atenolol, nortriptyline, and flunarizine.
TLDR
Pilot data is provided to support the use of Quetiapine (QTP) in the preventive treatment of refractory migraine, defined as previous unresponsiveness to the combination of atenolol, nortriptyline, and flunarizine. Expand
...
1
2
3
4
5
...